HSP90 as a new therapeutic target for cancer therapy: the story unfolds

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.1, 2002-01, pp. : 3-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J Lui Vivian Wai Yan Grandis Jennifer Rubin

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Can RNAi‐mediated hsp90α knockdown in combination with 17‐AAG be a therapy for glioma?

FEBS Open Bio, Vol. 3, Iss. 1, 2013-01 ,pp. : 271-278

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comparison of Hsp90α and Hsp90β interactions with cochaperones and substrates

By Taherian Aliakbar Krone Patrick H. Ovsenek Nick

Biochemistry and Cell Biology, Vol. 86, Iss. 1, 2008-02 ,pp. : 37-45

NRC Research Press

Access to resources Recommend Favorite

Hsp90 & Co. - a holding for folding

By Buchner J.

Trends in Biochemical Sciences, Vol. 24, Iss. 4, 1999-04 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Regulation of Pim-1 by Hsp90

By Mizuno K. Shirogane T. Shinohara A. Iwamatsu A. Hibi M. Hirano T.

Biochemical and Biophysical Research Communications, Vol. 281, Iss. 3, 2001-03 ,pp. : 663-669

Elsevier

Access to resources Recommend Favorite